![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[141]
刘新泳 and 展鹏.
利匹韦林合成路线图解.
《中国医药工业杂志》,
47,
352,
2016.
-
[142]
刘新泳 and 展鹏.
多拉韦林合成路线图解.
《中国药物化学杂志》,
26,
74,
2016.
-
[143]
刘新泳 and 展鹏.
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones .
Chem Biol Drug Des,
88,
380,
2016.
-
[144]
刘新泳 , 展鹏 and 刘慧青.
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
Bioorganic & medicinal chemistry,
2013.
-
[145]
展鹏 and 刘新泳.
Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents..
Mini-Rev Org. Chem.,
9,
397,
2012.
-
[146]
刘新泳 and 展鹏.
8-Hydroxyquinoline: A Privileged Structure with Broad-ranging Pharmacological Potentials.
MedChemComm,
6,
61,
2015.
-
[147]
展鹏 and 刘新泳.
HIV-1 NNRTIs: Structural diversity, pharmacophore similarity, and implications for drug design..
Med Res Rev.,
33,
E1,
2013.
-
[148]
刘新泳 and 展鹏.
二芳基胺类HIV-1 非核苷类逆转录酶抑制剂研究进展.
《中国药物化学杂志》,
2013.
-
[149]
刘新泳 , 展鹏 and 刘慧青.
Design, Synthesis and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Chann.
Chem Biol Drug Des,
86,
122,
2014.
-
[150]
刘新泳 , 刘慧青 and 展鹏.
Synthesis and preliminary antiviral activities of piperidine-substituted purines against HIV and inf.
Chem Biol Drug Des.,
2015.
-
[151]
刘新泳 , 刘慧青 and 展鹏.
Synthesis and biological evaluation of a series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthi.
Chem Biol Drug Des,
86,
614,
2015.
-
[152]
刘新泳 , 展鹏 and 刘慧青.
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,.
EUR J MED CHEM,
92C,
754,
2015.
-
[153]
刘新泳 , 展鹏 and 刘慧青.
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and.
Eur J Med Chem.,
93C,
330,
2015.
-
[154]
刘新泳 and 展鹏.
Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubi.
Expert Opin Ther Pat,
1,
2016.
-
[155]
刘新泳 and 展鹏.
Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
Expert Opin Drug Discov,
10,
1271,
2015.
-
[156]
刘新泳 and 展鹏.
先导化合物发现及优化新策略述评（一）.
中国科技论文,
10,
2140,
2015.
-
[157]
刘新泳 and 展鹏.
Non-nucleoside anti-HBV agents: Advances in structural optimization and mechanism of action investig.
MED CHEM COMM,
6,
521,
2015.
-
[158]
刘新泳 and 展鹏.
The changing face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A.
Curr Med Chem.,
22,
1860,
2015.
-
[159]
刘新泳 and 展鹏.
Discovery of HCV NS5B thumb site I inhibitors: Core-refining from benzimidazole to indole scaffold.
EUR J MED CHEM,
94,
218,
2015.
-
[160]
刘新泳 and 展鹏.
尼洛替尼的合成路线图解.
《中国医药工业杂志》,
46,
1143,
2015.
